Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.
NanoCas, an ultracompact nuclease, enables efficient muscle editing in NHPs using a single AAV - advancing gene editing for hard-to-target tissues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback